Aclaris Therapeutics, Inc. (ACRS)
2.90
-0.11
(-3.65%)
USD |
NASDAQ |
Dec 30, 16:00
2.91
+0.01
(+0.34%)
After-Hours: 20:00
Aclaris Therapeutics Market Cap: 314.20M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 7.384B |
| Puma Biotechnology, Inc. | 302.85M |
| Vivos Therapeutics, Inc. | 18.52M |
| CEL-SCI Corp. | 15.87M |
| AIM ImmunoTech, Inc. | 0.9629M |
Market Cap Related Metrics
| PS Ratio | 21.32 |
| PEG Ratio | -0.0127 |
| Price to Book Value | 2.616 |
| Price | 2.90 |
| Earnings Yield | -47.63% |
| PEGY Ratio | -0.0127 |